Dr Christopher Kripas | Pharmacovigilance Head
Moderna Therapeutics

Dr Christopher Kripas, Pharmacovigilance Head, Moderna Therapeutics

After completing his internal medicine residency and fellowship and board certification in Medical Oncology he worked as an Attending Physician for 8 years in the Urgent Care Center at Memorial-Sloan Cancer Center.  In 2006 Chris moved to the pharmaceutical industry working at Sanofi as a Global Safety Officer in Oncology based in Bridgewater, New Jersey.  There, he worked on numerous development programs, partnerships, and submissions, including the approval of the antiangiogenic aflibercept.
In 2011 he moved to Boston when Sanofi acquired Genzyme and remained in Oncology.  In late 2013 he moved to the position of Global Pharmacovigilance Head for the Sanofi-Genzyme Global Business Unit where he was responsible for the pharmacovigilance oversight for the therapeutic areas of Rare Disease, Multiple Sclerosis, Oncology and Immunology/Inflammation.  He is currently the Pharmacovigilance Head at Moderna Therapeutics in Cambridge Massachusetts. 

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071